1. ALTAMURA C. Argomenti di clinica e farmacoterapia delle psicosi maggiori. McGraw-Hill, Milano, 1996.

2. BASTOS M. Toxicological findings in victims of traumatic deaths. J Forensic Sciences, 1975.

3. BECH P. Mental illness and simulated driving: before and during treatment. Pharmakopsych Neuropsychopharmakol 1975; 8: 143-50.

4. BELLANTUONO C., TANSELLA M. Gli psicofarmaci nella pratica terapeutica. Il Pensiero Scientifico Editore, Roma. 1994.

5. CASSANO G.B. et al. Guida all’impiego del trattamento con clozapina. Suppl. Rivista di Psich 1996; 31, 4, lug.-ago.

6. CLAYTON AB et al. The effects of two antidepressants, imipramine and viloxazine, upon driving performance. Psychopharmacol 1977; 55: 9-12.

7. DE GIER JJ et al. Psychomotor performances and real driving performance of outpatients receiving diazepam. Psychopharmacol 1981; 73: 340-4.

8. DUREMAN I et al. Comparison studies of chlorazepate administered as divided daily dose and as a single dose at night. Psychopharmacol 1978; 57: 123-6.

9. ELLINWOOD EH Jr et al. Profile of acute tolerance to three sedative anxiolytics. Psychopharmacol 1983; 79: 137-41.

10. FAIRWEATHER DB et al. The behavioral toxicity of reversible inhibitors of monoamine oxidase A: laboratory and clinical investigation. J Clin Psychopharmacology 1995; 15: 4 suppl. 2, 68-75.

11 . GUARALDI GP et al. Il QCP come test di valutazione della idoneità alla guida in pazienti psichiatrici: uno studio pilota. Cl Psich, Ist di Med Leg, Univ di Modena, 1998, in corso di stampa.

12. GUARALDI GP et al. Psicopatologia e guida: review. Cl Psich, Ist di Med Legale, Univ di Modena, 1998, in corso di stampa.

13. HINDMARCH I. A pharmacological profile of fluoxetine and other antidepressants on aspects of skilled performance and car handling ability. Br J Psych 1988; 153, suppl. 3: 99-104.

14. HINDMARCH I. The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability, Br J Cl Pharmac 1980; 10: 145-150.

15. HINDMARCH I. The effects of paroxetine and other antidepressants in combination with alcohol in psychomotor activity related to car driving. Human Psychopharmacology 1988; 3, 13-20.

16. HINDMARCH I. The effects of zimeldine and amitriptyline on car driving and psychomotor performance. Acta Psy Scand 1983; suppl 308, 68, 141-146.

17. HINDRIK WJ. Acute and subchronic effects of paroxetine on actual driving psychomotor performance and subjective assessments in healthy volunteers. Europ Neuropsychopharmacology 1995; 5: 35-42.

18. HOBI V et al. How capable of driving are hospitalized psychiatric patients under psycho-active drug therapy? J Int Med Res 1981, 9: 434-47.

19. JOHNSON S, JOHNSON FN. Reviews in Contemporary Pharmacotherapy. Marius Press 1992; 3, 9.

20. KAWAZU Y. Personality trait and antianxiety drug effects on psychomotor performance. Prog Neuro-psychopharmacol 1980; 4, 285-292.

21. KERR JS. The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly. International Cl Psychopharmac 1992; 7: 101-108.

22. KEVAN R. WYLIE. Effects of depot neuroleptics on driving performance in chronic schizophrenic patients. J Neurol, Neurosurgery, Psychiatry 1993; 56: 910-913.

23. KOZENA L et al. Vigilance impairment after a single dose of BDZ. Psychopharmacol 1995; 119: 39-45.

24. MAKI M. Characteristics of driving in relation to the drug and alcohol use of Finnish outpatients. Mod Probl Pharmacopsc 1976; 11: 11-21.

25. MERCIER-GUYON C. Studio degli effetti del bromazepam sulla vigilanza e le performances psicomotorie nei piloti di rally. La Gazzette Médicale 1987; 94, aprile.

26. MILNER G. Alcohol, tioridazine and chlorpromazine effects on driving behavior. Br J Psyc 1970.

27. MOLFESE A. Assunzione di farmaci psicotropi e guida degli autoveicoli. Bollettino d’informazione sui farmaci, 1996; 6-7.

28. MOORE NC. Medazepam and driving ability of anxious patients. Psychopharmacol (Berl.), 1977; 52: 103-6.

29. O’HANLON J. Diazepam impairs lateral position control in highway driving. Science 1982; 217, July.

30. O’HANLON J et al. Antihistamine effects on actual driving performance in a standard test: a summary of dutch experience, 1989-94. Allergy 1995; 50: 234-42.

31. O’HANLON J et al. Anxiolitics’ effects on actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies. Neuropsychobiology 1995; 31: 81-8.

32. OTT H. Are electroencephalographic and psychomotor measures sensitive in detecting residual sequelae of BDZ Hypnotics? Psychopharmacol 1984; suppl. 1: 133-51.

33. PENTTILA A et al. Psychotropic drug and impairment of psychomotor functions. Psychopharmacologia 1975; 43: 75-80.

34. RAMAEKERS JG et al. A cross-study comparison of the effects of moclobemide and brofaromine on actual driving performance and estimated sleep. Clin Neuropharmacol 1994; 17 suppl. 1: 9-18.

35. RAMAEKERS JG et al. A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. Br J Clin Pharmacol 1995; 39: 397-404.

36. RAMAEKERS JG et al. Effects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters relative to placebo. Psychopharmacol 1992; 106 suppl: 62-7.

37. RUSSEL NOYES. Motor vehicle accidents related to psychiatric impairment. 1985; 27, 7, July.

38. SEPPALA T. Two weeks’ treatment with chloropromazine, thioridazine, sulpiride or bromazepam: actions and interactions with alcohol on psychomotor skills related to driving. Mod Prob Pharmacopsych 1976, 11, 85-90.

39. SERVAN-SCHREIBER D et al. Neuroleptic effects on acquisition and performance of learned behaviors: a reinterpretation. Life Sci 1995, 56: 2239-45.

40. SILVERSTONE T. The influence of psychiatric disease and its treatment on driving performance. Int Clin Psychopharmacol 1988, 3.

41. SKEGG CG. Minor tranquilisers and road accidents. British Medical J 1979; April.

42. TSUANG T MING. Psychiatric aspects of traffic accidents. Am J Psychiatry 1985; 142: 5, May.

43. VUURMAN EF et al. Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers. Eur J Clin Pharmachol 1994; 47: 253-9.

44. WILLUMEIT HP et al. Simulated car driving as useful technique for the determination of residual effects and alcohol interaction after short and long-acting BDZ. Psychopharmacol 1984; suppl. 1: 182-92.